Praxis precision medicines to host epilepsy day on april 27, 2022

Boston, april 13, 2022 (globe newswire) -- praxis precision medicines, inc. (nasdaq: prax), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (cns) disorders characterized by neuronal excitation-inhibition imbalance, today announced that the company will host an epilepsy day from 8:30 a.m. to 11:30 a.m. et on wednesday, april 27, 2022 virtually and in new york city.
PRAX Ratings Summary
PRAX Quant Ranking